Presents ICH Q8, Q9, and Q10 as an integrated quality system designed to ensure product quality and reduce risk throughout the entire product lifecycle.
Explains the fundamental shift in GMP philosophy from a reactive approach (testing quality in at the end) to a proactive, science- and risk-based approach (building quality into the design).
Identifies key themes of modern GMP, including Quality Risk Management, Knowledge Management for technology transfer, a focus on the entire product lifecycle, and the drive for continuous improvement.
Emphasizes the critical role of management commitment and ownership in successfully implementing a modern Pharmaceutical Quality System.
Advocates for Quality by Design (QbD) from a practical manufacturing perspective, highlighting its benefits in improving technology transfer, deviation investigations, and change control.
Discusses the real-world challenges of implementing QbD, including the need for corporate investment, management buy-in, and specialized statistical expertise.
